SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Dr Lal Pathlabs

BSE: 539524 29 Sep 2025
Healthcare
₹ 3296
Dr. Lal Pathlabs Limited specializes in Healthcare Service Provider within the Healthcare sector.

Dr Lal Pathlabs - Share Price & Details

Market Cap
₹26,762
High /Low
3,654 / 2,294
Stock P/E
52.2
Book Value
₹260.0
Dividend Yield
0.75
ROCE
28.9
ROE
₹24.3
Face Value
10.0
PEG Ratio
4.25
EVEBITDA
₹31.9
Debt
157
CMP / FCF
57.1
Debt to equity
₹0.07
NP Ann
492
High price all time
4,246
Piotroski score
₹8.0
Graham Number
599.0
No. Eq. Shares
8.38
Net CF
₹-68.3
Net profit
518
Price to book value
12.3
Interest Coverage
₹32.2
Low price all time
696.0
Industry PE
38.6
Reserves
₹2,089
Free Cash Flow
₹516

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
20 Jul 2025 Emkay Global Financial Services Buy ₹3,000.75 ₹3,100 3.1% moneycontrol View
26 Apr 2025 Emkay Global Financial Services Buy ₹2,906.55 ₹3,100 10.2% moneycontrol View
26 Apr 2025 ICICI Securities Hold ₹2,906.55 ₹2,900 4.3% moneycontrol View
30 Jan 2025 Emkay Global Financial Services Buy ₹2,879.4 ₹3,250 13.5% moneycontrol View
24 Oct 2024 ICICI Securities Hold ₹3,053.5 ₹3,100 3.7% moneycontrol View
08 Aug 2024 ICICI Securities Hold ₹3,194.75 ₹3,240 8.4% moneycontrol View
10 May 2024 Emkay Global Financial Services Buy ₹2,348.85 ₹2,800 -5.8% moneycontrol View

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
Dr. Lal Pathlabs Limited6670.01293.06407.015.4926,76252.2
J.B.CHEMICALS & PHARMACEUTICAL10538.01978.710399.012.482615338.2
PIRAMAL PHARMA LIMITED11508.01131.49698.80.8524954289.0

Peer Comparison Chart


About Dr Lal Pathlabs

Dr. Lal Pathlabs Limited, with Security Code 539524, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Dr Lal PathLabs Ltd (DLPL IN): Here’s Why Growth to Accelerate and Margin to Improve

(20 Sep 2025)
Dr Lal PathLabs sees strong start to FY26 with double-digit growth driven by volume expansion resulting from expanding geographic presence.
Read more →

Daily Brief Health Care: Vivani Medical, Medcaptain Medical Technology, Dr Lal PathLabs Ltd, Immix Biopharma Inc, MDxHealth SA, Oncology Institute and more

(20 Sep 2025)
Vivani Medical has set Oct 8, 2025 as teh record date for its earlier announced spin-off of its neuromodulation subsidiary, Cortigent Inc.
Read more →

Dr. Lal PathLabs Limited's (NSE:LALPATHLAB): Top Key Executive Arvind Lal is the most bullish insider, and their stock value gained 3.2% last week

(16 Sep 2025)
Key Insights Dr. Lal PathLabs' significant insider ownership suggests inherent interests in company's expansion A total...
Read more →

From Partition to Pandemic, How Dr Lal PathLabs Built an Indian Diagnostics Empire

(30 Aug 2025)
Dr Lal PathLabs, founded by Dr SK Lal in 1949, has grown into one of India's largest diagnostics chains. With a legacy of accuracy and trust...
Read more →

Dr. Lal PathLabs to Hold Analyst/Institutional Investor Meetings in September 2025

(26 Aug 2025)
Dr. Lal PathLabs has announced that it will be holding meetings with analysts and institutional investors in September 2025.
Read more →

Dr. Lal PathLabs pioneers AI integration in cancer diagnosis in India

(25 Aug 2025)
In a pioneering move set to transform cancer diagnostics in India, Dr. Lal PathLabs (DLPL) has become the first laboratory in the country to...
Read more →